Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death (original) (raw)

• Deshaies, R. J. & Joazeiro, C. A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399–434 (2009).
  CAS PubMed Google Scholar
• Pickart, C. M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503–533 (2001).
  CAS PubMed Google Scholar
• Deshaies, R. J. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15, 435–467 (1999).
  CAS PubMed Google Scholar
• Ikeda, F. & Dikic, I. Atypical ubiquitin chains: new molecular signals. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep. 9, 536–542 (2008).
  CAS PubMed PubMed Central Google Scholar
• Eddins, M. J., Carlile, C. M., Gomez, K. M., Pickart, C. M. & Wolberger, C. Mms2–Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nature Struct. Mol. Biol. 13, 915–920 (2006).
  CAS Google Scholar
• Rodrigo-Brenni, M. C., Foster, S. A. & Morgan, D. O. Catalysis of lysine 48-specific ubiquitin chain assembly by residues in E2 and ubiquitin. Mol. Cell 39, 548–559 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wickliffe, K. E., Lorenz, S., Wemmer, D. E., Kuriyan, J. & Rape, M. The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell 144, 769–781 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kirkin, V. & Dikic, I. Role of ubiquitin- and Ubl-binding proteins in cell signaling. Curr. Opin. Cell Biol. 19, 199–205 (2007).
  CAS PubMed Google Scholar
• Finley, D., Ciechanover, A. & Varshavsky, A. Ubiquitin as a central cellular regulator. Cell 116, S29–S32 (2004).
  CAS PubMed Google Scholar
• Salvesen, G. S. & Abrams, J. M. Caspase activation — stepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene 23, 2774–2784 (2004).
  CAS PubMed Google Scholar
• Kaufmann, S. H. & Vaux, D. L. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22, 7414–7430 (2003).
  CAS PubMed Google Scholar
• Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nature Rev. Mol. Cell Biol. 9, 47–59 (2008).
  CAS Google Scholar
• Du, C., Fang, M., Li, Y., Li, L. & Wang, X. Smac, a mitochondrial protein that promotes cytochrome _c_-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33–42 (2000).
  CAS PubMed Google Scholar
• Liu, X., Kim, C. N., Yang, J., Jemmerson, R. & Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147–157 (1996).
  CAS PubMed Google Scholar
• Verhagen, A. M. et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43–53 (2000).
  CAS PubMed Google Scholar
• Riedl, S. J. & Salvesen, G. S. The apoptosome: signalling platform of cell death. Nature Rev. Mol. Cell Biol. 8, 405–413 (2007).
  CAS Google Scholar
• Ashkenazi, A. & Dixit, V. M. Death receptors: signaling and modulation. Science 281, 1305–1308 (1998).
  CAS PubMed Google Scholar
• Guicciardi, M. E. & Gores, G. J. Life and death by death receptors. FASEB J. 23, 1625–1637 (2009).
  CAS PubMed PubMed Central Google Scholar
• Strasser, A., Jost, P. J. & Nagata, S. The many roles of FAS receptor signaling in the immune system. Immunity 30, 180–192 (2009).
  CAS PubMed PubMed Central Google Scholar
• Tschopp, J., Irmler, M. & Thome, M. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10, 552–558 (1998).
  CAS PubMed Google Scholar
• Salvesen, G. S. & Duckett, C. S. IAP proteins: blocking the road to death's door. Nature Rev. Mol. Cell Biol. 3, 401–410 (2002).
  CAS Google Scholar
• Vucic, D. et al. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP. Biochem. J. 385, 11–20 (2005).
  CAS PubMed Google Scholar
• Vousden, K. H. & Prives, C. Blinded by the light: the growing complexity of p53. Cell 137, 413–431 (2009).
  CAS PubMed Google Scholar
• Huang, J., Plass, C. & Gerhäuser, C. Cancer chemoprevention by targeting the epigenome. Curr. Drug Targets. 15 Dec 2010 [epub ahead of print].
• Declercq, W., Vanden Berghe, T. & Vandenabeele, P. RIP kinases at the crossroads of cell death and survival. Cell 138, 229–232 (2009).
  CAS PubMed Google Scholar
• Wertz, I. E. & Dixit, V. M. Regulation of death receptor signaling by the ubiquitin system. Cell Death Differ. 17, 14–24 (2010).
  CAS PubMed Google Scholar
• Zhang, H. G., Wang, J., Yang, X., Hsu, H. C. & Mountz, J. D. Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 23, 2009–2015 (2004).
  CAS PubMed Google Scholar
• Steller, H. Regulation of apoptosis in Drosophila. Cell Death Differ. 15, 1132–1138 (2008).
  CAS PubMed Google Scholar
• Sandu, C., Ryoo, H. D. & Steller, H. Drosophila IAP antagonists form multimeric complexes to promote cell death. J. Cell Biol. 190, 1039–1052 (2010).
  CAS PubMed PubMed Central Google Scholar
• Koto, A., Kuranaga, E. & Miura, M. Temporal regulation of Drosophila IAP1 determines caspase functions in sensory organ development. J. Cell Biol. 187, 219–231 (2009).
  CAS PubMed PubMed Central Google Scholar
• Broemer, M. et al. Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases. Mol. Cell 40, 810–822 (2010).
  CAS PubMed Google Scholar
• Ditzel, M. et al. Inactivation of effector caspases through nondegradative polyubiquitylation. Mol. Cell 32, 540–553 (2008).
  CAS PubMed PubMed Central Google Scholar
• Bader, M., Arama, E. & Steller, H. A novel F-box protein is required for caspase activation during cellular remodeling in Drosophila. Development 137, 1679–1688 (2010).
  CAS PubMed PubMed Central Google Scholar
• Eckelman, B. P., Salvesen, G. S. & Scott, F. L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7, 988–994 (2006).
  CAS PubMed PubMed Central Google Scholar
• Suzuki, Y., Nakabayashi, Y. & Takahashi, R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl Acad. Sci. USA 98, 8662–8667 (2001).
  CAS PubMed PubMed Central Google Scholar
• Schile, A. J., Garcia-Fernandez, M. & Steller, H. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 22, 2256–2266 (2008). Demonstrates the importance of XIAP ubiquitin ligase activity for the regulation of apoptosis.
  CAS PubMed PubMed Central Google Scholar
• Choi, Y. E. et al. The E3 ubiquitin ligase c-IAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing. J. Biol. Chem. 284, 12772–12782 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hu, S. & Yang, X. Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J. Biol. Chem. 278, 10055–10060 (2003).
  CAS PubMed Google Scholar
• MacFarlane, M., Merrison, W., Bratton, S. B. & Cohen, G. M. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J. Biol. Chem. 277, 36611–36616 (2002).
  CAS PubMed Google Scholar
• Conze, D. B. et al. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell. Biol. 25, 3348–3356 (2005).
  CAS PubMed PubMed Central Google Scholar
• Silke, J. et al. Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc. Natl Acad. Sci. USA 102, 16182–16187 (2005).
  CAS PubMed PubMed Central Google Scholar
• Dogan, T. et al. X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility. Nature Cell Biol. 10, 1447–1455 (2008).
  CAS PubMed Google Scholar
• Xu, L. et al. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1. Mol. Cell 28, 914–922 (2007).
  CAS PubMed Google Scholar
• Li, X., Yang, Y. & Ashwell, J. D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416, 345–347 (2002).
  PubMed Google Scholar
• Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181–190 (2003). The first description of two distinct signalling complexes initiated by TNFR1 activation that differentially regulate apoptosis and are modulated by distinct ubiquitylation events.
  CAS PubMed Google Scholar
• Rothe, M., Pan, M. G., Henzel, W. J., Ayres, T. M. & Goeddel, D. V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243–1252 (1995). The authors identify c-IAP proteins in a TNFR-associated signalling complex.
  CAS PubMed Google Scholar
• Bertrand, M. J. et al. c-IAP1 and c-IAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689–700 (2008).
  CAS PubMed Google Scholar
• Dynek, J. N. et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 29, 4198–4209 (2010).
  CAS PubMed PubMed Central Google Scholar
• Varfolomeev, E. et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. J. Biol. Chem. 283, 24295–24299 (2008). References 47 and 49 identify c-IAP1 and c-IAP2 as ubiquitin ligases for RIP1.
  CAS PubMed PubMed Central Google Scholar
• Mahoney, D. J. et al. Both c-IAP1 and c-IAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl Acad. Sci. USA 105, 11778–11783 (2008).
  CAS PubMed PubMed Central Google Scholar
• Ikeda, F., Crosetto, N. & Dikic, I. What determines the specificity and outcomes of ubiquitin signaling? Cell 143, 677–681 (2010).
  CAS PubMed Google Scholar
• Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591–596 (2011).
  CAS PubMed Google Scholar
• Xu, M., Skaug, B., Zeng, W. & Chen, Z. J. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Mol. Cell 36, 302–314 (2009).
  CAS PubMed PubMed Central Google Scholar
• Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831–844 (2009).
  CAS PubMed Google Scholar
• Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nature Cell Biol. 11, 123–132 (2009). The first description of linear polyubiquitination in TNF signalling.
  CAS PubMed Google Scholar
• Ikeda, F. et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471, 637–641 (2011).
  CAS PubMed PubMed Central Google Scholar
• Tokunaga, F. et al. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471, 633–636 (2011).
  CAS PubMed Google Scholar
• Vallabhapurapu, S. et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nature Immunol. 9, 1364–1370 (2008).
  CAS Google Scholar
• Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669–681 (2007). Provides evidence that IAP antagonists activate ubiquitin ligase activity of c-IAP proteins and identifies these proteins as crucial E3 ligases for NIK.
  CAS PubMed Google Scholar
• Vince, J. E. et al. IAP antagonists target c-IAP1 to induce TNFα-dependent apoptosis. Cell 131, 682–693 (2007). Further evidence that IAP antagonists activate ubiquitin ligase activity of c-IAP proteins.
  CAS PubMed Google Scholar
• Zarnegar, B. J. et al. Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors c-IAP1, c-IAP2, TRAF2 and TRAF3 and the kinase NIK. Nature Immunol. 9, 1371–1378 (2008).
  CAS Google Scholar
• Vince, J. E. et al. TWEAK-FN14 signaling induces lysosomal degradation of a c-IAP1-TRAF2 complex to sensitize tumor cells to TNFα. J. Cell Biol. 182, 171–184 (2008).
  CAS PubMed PubMed Central Google Scholar
• Dejardin, E. The alternative NF-κB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol. 72, 1161–1179 (2006).
  CAS PubMed Google Scholar
• Varfolomeev, E. & Vucic, D. (Un)expected roles of c-IAPs in apoptotic and NF-κB signaling pathways. Cell Cycle 7, 1511–1521 (2008).
  CAS PubMed Google Scholar
• Matsuzawa, A. et al. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321, 663–668 (2008).
  CAS PubMed PubMed Central Google Scholar
• Gardam, S. et al. Deletion of c-IAP1 and c-IAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood 117, 4041–4051 (2011).
  CAS PubMed Google Scholar
• Petersen, S. L. et al. Autocrine TNFα signaling renders human cancer cells susceptible to smac-mimetic-induced apoptosis. Cancer Cell 12, 445–456 (2007).
  CAS PubMed PubMed Central Google Scholar
• Vandenabeele, P., Galluzzi, L., Vanden Berghe, T. & Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Rev. Mol. Cell Biol. 11, 700–714 (2010).
  CAS Google Scholar
• Conze, D. B., Zhao, Y. & Ashwell, J. D. Non-canonical NF-κB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2. PLoS Biol. 8, e1000518 (2010).
  PubMed PubMed Central Google Scholar
• Zilfou, J. T. & Lowe, S. W. Tumor suppressive functions of p53. Cold Spring Harb. Perspect. Biol. 1, a001883 (2009).
  PubMed PubMed Central Google Scholar
• Jain, A. K. & Barton, M. C. Making sense of ubiquitin ligases that regulate p53. Cancer Biol. Ther. 10, 665–672 (2010).
  CAS PubMed PubMed Central Google Scholar
• Brady, C. A. & Attardi, L. D. p53 at a glance. J. Cell Sci. 123, 2527–2532 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wade, M., Wang, Y. V. & Wahl, G. M. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 20, 299–309 (2010).
  CAS PubMed PubMed Central Google Scholar
• Huang, H. & Tindall, D. J. Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim. Biophys. Acta 14 Jan 2011 (doi:10.1016/j.bbamcr.2011.01.007).
  CAS Google Scholar
• Marine, J. C. & Lozano, G. Mdm2-mediated ubiquitylation: p53 and beyond. Cell Death Differ. 17, 93–102 (2010).
  CAS PubMed Google Scholar
• Maguire, M. et al. MDM2 regulates dihydrofolate reductase activity through monoubiquitination. Cancer Res. 68, 3232–3242 (2008).
  CAS PubMed PubMed Central Google Scholar
• Zhu, Y. et al. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol. Cell 35, 316–326 (2009).
  CAS PubMed PubMed Central Google Scholar
• Itahana, K. et al. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 12, 355–366 (2007).
  CAS PubMed Google Scholar
• Inuzuka, H. et al. Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCFβ-TRCP ubiquitin ligase. Cancer Cell 18, 147–159 (2010).
  CAS PubMed PubMed Central Google Scholar
• Brooks, C. L. & Gu, W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21, 307–315 (2006).
  CAS PubMed PubMed Central Google Scholar
• Rossi, M. et al. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J. 24, 836–848 (2005).
  CAS PubMed PubMed Central Google Scholar
• Melino, G., Knight, R. A. & Cesareni, G. Degradation of p63 by Itch. Cell Cycle 5, 1735–1739 (2006).
  CAS PubMed Google Scholar
• Chang, L. et al. The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIPL turnover. Cell 124, 601–613 (2006).
  CAS PubMed Google Scholar
• Winter, M. et al. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nature Cell Biol. 10, 812–824 (2008).
  CAS PubMed Google Scholar
• Garrison, J. B. et al. ARTS and Siah collaborate in a pathway for XIAP degradation. Mol. Cell 41, 107–116 (2011).
  CAS PubMed Google Scholar
• Gottfried, Y., Rotem, A., Lotan, R., Steller, H. & Larisch, S. The mitochondrial ARTS protein promotes apoptosis through targeting XIAP. EMBO J. 23, 1627–1635 (2004).
  CAS PubMed PubMed Central Google Scholar
• Nakayama, K. & Ronai, Z. Siah: new players in the cellular response to hypoxia. Cell Cycle 3, 1345–1347 (2004).
  CAS PubMed Google Scholar
• Kaelin, W. G. Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74, 115–128 (2005).
  CAS PubMed Google Scholar
• Skaar, J. R., D'Angiolella, V., Pagan, J. K. & Pagano, M. SnapShot: F box proteins II. Cell 137, 1358.e1–1358.e2 (2009).
  Google Scholar
• Frescas, D. & Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nature Rev. Cancer 8, 438–449 (2008).
  CAS Google Scholar
• Feinstein-Rotkopf, Y. & Arama, E. Can't live without them, can live with them: roles of caspases during vital cellular processes. Apoptosis 14, 980–995 (2009).
  PubMed Google Scholar
• Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263–274, (1996).
  CAS PubMed Google Scholar
• Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell 4, 799–812 (2003).
  CAS PubMed Google Scholar
• Nakayama, K. et al. Impaired degradation of inhibitory subunit of NF-κB (IκB) and β-catenin as a result of targeted disruption of the β-TrCP1 gene. Proc. Natl Acad. Sci. USA 100, 8752–8757 (2003).
  CAS PubMed PubMed Central Google Scholar
• Busino, L. et al. Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 426, 87–91 (2003).
  CAS PubMed Google Scholar
• Soldatenkov, V. A., Dritschilo, A., Ronai, Z. & Fuchs, S. Y. Inhibition of homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis. Cancer Res. 59, 5085–5088 (1999).
  CAS PubMed Google Scholar
• Dehan, E. et al. βTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis. Mol. Cell 33, 109–116 (2009).
  CAS PubMed PubMed Central Google Scholar
• Tan, M. et al. SAG–ROC-SCFβ-TrCP E3 ubiquitin ligase promotes pro–caspase-3 degradation as a mechanism of apoptosis protection. Neoplasia 8, 1042–1054 (2006).
  CAS PubMed PubMed Central Google Scholar
• Gallegos, J. R. et al. SCFβTrCP1 activates and ubiquitylates TAp63γ. J. Biol. Chem. 283, 66–75 (2008).
  CAS PubMed Google Scholar
• Xia, Y. et al. Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP. Proc. Natl Acad. Sci. USA 106, 2629–2634 (2009).
  CAS PubMed PubMed Central Google Scholar
• Soond, S. M. et al. ERK and the F-box protein βTRCP target STAT1 for degradation. J. Biol. Chem. 283, 16077–16083 (2008).
  CAS PubMed PubMed Central Google Scholar
• Dorrello, N. V. et al. S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314, 467–471 (2006).
  CAS PubMed Google Scholar
• Ding, Q. et al. Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol. Cell. Biol. 27, 4006–4017 (2007).
  CAS PubMed Google Scholar
• Kanemori, Y., Uto, K. & Sagata, N. β-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Proc. Natl Acad. Sci. USA 102, 6279–6284 (2005).
  CAS PubMed PubMed Central Google Scholar
• Tetzlaff, M. T. et al. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc. Natl Acad. Sci. USA 101, 3338–3345 (2004).
  CAS PubMed PubMed Central Google Scholar
• Welcker, M. & Clurman, B. E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nature Rev. Cancer 8, 83–93 (2008).
  CAS Google Scholar
• Hoeck, J. D. et al. Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun. Nature Neurosci. 13, 1365–1372 (2010).
  CAS PubMed Google Scholar
• Crusio, K. M., King, B., Reavie, L. B. & Aifantis, I. The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation. Oncogene 29, 4865–4873 (2010).
  CAS PubMed PubMed Central Google Scholar
• Schwanbeck, R., Martini, S., Bernoth, K. & Just, U. The Notch signaling pathway: molecular basis of cell context dependency. Eur. J. Cell Biol. 90, 572–581 (2010).
  PubMed Google Scholar
• Mazumder, S., DuPree, E. L. & Almasan, A. A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy. Curr. Cancer Drug Targets 4, 65–75 (2004).
  CAS PubMed PubMed Central Google Scholar
• Moberg, K. H., Mukherjee, A., Veraksa, A., Artavanis-Tsakonas, S. & Hariharan, I. K. The Drosophila F-box protein Archipelago regulates dMyc protein levels in vivo. Curr. Biol. 14, 965–974 (2004).
  CAS PubMed Google Scholar
• Nateri, A. S., Riera-Sans, L., Da Costa, C. & Behrens, A. The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303, 1374–1378 (2004).
  CAS PubMed Google Scholar
• Welcker, M. et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl Acad. Sci. USA 101, 9085–9090 (2004).
  CAS PubMed PubMed Central Google Scholar
• Yada, M. et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23, 2116–2125 (2004).
  CAS PubMed PubMed Central Google Scholar
• Sánchez, I. & Yuan, J. A convoluted way to die. Neuron 29, 563–566 (2001).
  PubMed Google Scholar
• Inuzuka, H. et al. SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 471, 104–109 (2011).
  CAS PubMed PubMed Central Google Scholar
• Wertz, I. E. et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 471, 110–114 (2011).
  CAS PubMed Google Scholar
• Zhong, Q., Gao, W., Du, F. & Wang, X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121, 1085–1095 (2005).
  CAS PubMed Google Scholar
• Harley, M. E., Allan L. A., Sanderson H. S. & Clarke, P. R. Phosphorylation of Mcl-1 by CDK1–cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J. 29, 2407–2420 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wertz, I. E. & Dixit, V. M. Signaling to NF-κB: regulation by ubiquitination. Cold Spring Harb. Perspect. Biol. 2, a003350 (2010).
  PubMed PubMed Central Google Scholar
• Vaux, D. L. & Silke, J. IAPs, RINGs and ubiquitylation. Nature Rev. Mol. Cell Biol. 6, 287–297 (2005).
  CAS Google Scholar
• Bosanac, I. et al. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. Mol. Cell 40, 548–557 (2010).
  CAS PubMed Google Scholar
• Heyninck, K. & Beyaert, R. A20 inhibits NFκB activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 30, 1–4 (2005).
  CAS PubMed Google Scholar
• Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694–699 (2004).
  CAS PubMed Google Scholar
• Dixit, V. M. et al. Tumor necrosis factor-α induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J. Biol. Chem. 265, 2973–2978 (1990).
  CAS PubMed Google Scholar
• Krikos, A., Laherty, C. D. & Dixit, V. M. Transcriptional activation of the tumor necrosis factor α-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol. Chem. 267, 17971–17976 (1992).
  CAS PubMed Google Scholar
• Hymowitz, S. G. & Wertz, I. E. A20: from ubiquitin editing to tumour suppression. Nature Rev. Cancer 10, 332–341 (2010).
  CAS Google Scholar
• Lee, E. G. et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289, 2350–2354 (2000). Reveals the critical importance of the A20 protein in regulating NF-κB signalling.
  CAS PubMed PubMed Central Google Scholar
• Verstrepen, L. et al. Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem. Pharmacol. 80, 2009–2020 (2010).
  CAS PubMed Google Scholar
• Wertz, I. E. et al. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 303, 1371–1374 (2004).
  CAS PubMed Google Scholar
• Vereecke, L. et al. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis. J. Exp. Med. 207, 1513–1523 (2010).
  CAS PubMed PubMed Central Google Scholar
• Malynn, B. A. & Ma, A. Ubiquitin makes its mark on immune regulation. Immunity 33, 843–852 (2010).
  CAS PubMed PubMed Central Google Scholar
• Jin, Z. et al. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137, 721–735 (2009).
  CAS PubMed Google Scholar
• Bignell, G. R. et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nature Genet. 25, 160–165 (2000). Describes the characterization of the CYLD tumour suppressor gene.
  CAS PubMed Google Scholar
• Saggar, S. et al. CYLD mutations in familial skin appendage tumours. J. Med. Genet. 45, 298–302 (2008).
  CAS PubMed Google Scholar
• Sun, S. C. CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes. Cell Death Differ. 17, 25–34 (2010).
  CAS PubMed Google Scholar
• Kovalenko, A. et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424, 801–805 (2003).
  CAS PubMed Google Scholar
• Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A. & Fassler, R. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling. Cell 125, 665–677 (2006).
  CAS PubMed Google Scholar
• Zhang, J. et al. Impaired regulation of NF-κB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J. Clin. Invest. 116, 3042–3049 (2006).
  CAS PubMed PubMed Central Google Scholar
• Wright, A. et al. Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD. Dev. Cell 13, 705–716 (2007).
  CAS PubMed Google Scholar
• Wang, L., Du, F. & Wang, X. TNF-α induces two distinct caspase-8 activation pathways. Cell 133, 693–703 (2008).
  CAS PubMed Google Scholar
• Vanlangenakker, N. et al. c-IAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ. 18, 656–665 (2011).
  CAS PubMed Google Scholar
• Lee, M. J., Lee, B. H., Hanna, J., King, R. W. & Finley, D. Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes. Mol. Cell Proteomics 10, R110.003871 (2010).
  PubMed PubMed Central Google Scholar
• Crimmins, S. et al. Transgenic rescue of ataxia mice reveals a male-specific sterility defect. Dev. Biol. 325, 33–42 (2009).
  CAS PubMed Google Scholar
• Ehlers, M. D. Ubiquitin and synaptic dysfunction: ataxic mice highlight new common themes in neurological disease. Trends Neurosci. 26, 4–7 (2003).
  CAS PubMed Google Scholar
• Crimmins, S. et al. Transgenic rescue of ataxia mice with neuronal-specific expression of ubiquitin-specific protease 14. J. Neurosci. 26, 11423–11431 (2006).
  CAS PubMed PubMed Central Google Scholar
• Lee, B. H. et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179–184 (2010). The authors describe the development of a USP14 small molecule inhibitor to definitively demonstrate the role of USP14 in ubiquitin chain editing at the proteasome.
  CAS PubMed PubMed Central Google Scholar
• Shi, D. & Grossman, S. R. Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets. Cancer Biol. Ther. 10, 737–747 (2010).
  CAS PubMed PubMed Central Google Scholar
• Pantaleon, M. et al. FAM deubiquitylating enzyme is essential for preimplantation mouse embryo development. Mech. Dev. 109, 151–160 (2001).
  CAS PubMed Google Scholar
• Sacco, J. J., Coulson, J. M., Clague, M. J. & Urbe, S. Emerging roles of deubiquitinases in cancer-associated pathways. IUBMB life 62, 140–157 (2010).
  CAS PubMed PubMed Central Google Scholar
• Jolly, L. A., Taylor, V. & Wood, S. A. USP9X enhances the polarity and self-renewal of embryonic stem cell-derived neural progenitors. Mol. Biol. Cell 20, 2015–2029 (2009).
  CAS PubMed PubMed Central Google Scholar
• Wrana, J. L. The secret life of Smad4. Cell 136, 13–14 (2009).
  CAS PubMed Google Scholar
• Schwickart, M. et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463, 103–107 (2010).
  CAS PubMed Google Scholar
• Nagai, H. et al. Ubiquitin-like sequence in ASK1 plays critical roles in the recognition and stabilization by USP9X and oxidative stress-induced cell death. Mol. Cell 36, 805–818 (2009).
  CAS PubMed Google Scholar
• Everett, R. D. et al. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16, 1519–1530 (1997).
  CAS PubMed PubMed Central Google Scholar
• Faustrup, H., Bekker-Jensen, S., Bartek, J., Lukas, J. & Mailand, N. USP7 counteracts SCFβTrCP- but not APCCdh1-mediated proteolysis of Claspin. J. Cell Biol. 184, 13–19 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  CAS PubMed Google Scholar
• Sureda, F. X. et al. Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases. Curr. Pharm. Des. 17, 230–245 (2011).
  CAS PubMed Google Scholar
• Dynek, J. N. et al. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res. 68, 3124–3132 (2008).
  CAS PubMed Google Scholar
• Hunter, A. M., LaCasse, E. C. & Korneluk, R. G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12, 1543–1568 (2007).
  CAS PubMed Google Scholar
• Imoto, I. et al. Expression of c-IAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. Cancer Res. 62, 4860–4866 (2002).
  CAS PubMed Google Scholar
• Dierlamm, J. et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa- associated lymphoid tissue lymphomas. Blood 93, 3601–3609 (1999).
  CAS PubMed Google Scholar
• Isaacson, P. G. Update on MALT lymphomas. Best Pract. Res. Clin. Haematol. 18, 57–68 (2005).
  CAS PubMed Google Scholar
• Zhou, H., Du, M. Q. & Dixit, V. M. Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 7, 425–431 (2005).
  CAS PubMed Google Scholar
• Ndubaku, C., Cohen, F., Varfolomeev, E. & Vucic, D. Targeting inhibitor of apoptosis (IAP) proteins for therapeutic intervention. Future Med. Chem. 1, 1509–1525 (2009).
  CAS PubMed Google Scholar
• Sun, H. et al. Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP. J. Am. Chem. Soc. 129, 15279–15294 (2007).
  CAS PubMed PubMed Central Google Scholar
• Vereecke, L., Beyaert, R. & van Loo, G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 30, 383–391 (2009).
  CAS PubMed Google Scholar
• Coornaert, B. et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20. Nature Immunol. 9, 263–271 (2008).
  CAS Google Scholar
• Duwel, M. et al. A20 negatively regulates T cell receptor signaling to NF-κB by cleaving Malt1 ubiquitin chains. J. Immunol. 182, 7718–7728 (2009).
  PubMed Google Scholar
• Malynn, B. A. & Ma, A. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme. J. Exp. Med. 206, 977–980 (2009).
  CAS PubMed PubMed Central Google Scholar
• Dynek, J. N. & Vucic, D. Antagonists of IAP proteins as cancer therapeutics. Cancer Lett. 2 Aug 2010 (doi:10.1016/j.canlet.2010.06.013).
  CAS PubMed Google Scholar
• Baud, V. & Karin, M. Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nature Rev. Drug Discov. 8, 33–40 (2009).
  CAS Google Scholar
• Packham, G. The role of NF-κB in lymphoid malignancies. Br. J. Haematol. 143, 3–15 (2008).
  CAS PubMed Google Scholar
• Baker, K. P. et al. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 48, 3253–3265 (2003).
  CAS PubMed Google Scholar
• Cummings, S. R. et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N. Engl. J. Med. 361, 756–765 (2009).
  CAS PubMed Google Scholar
• Tse, C. et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res. 68, 3421–3428 (2008).
  CAS PubMed Google Scholar
• Karin, M. The IκB kinase — a bridge between inflammation and cancer. Cell Res. 18, 334–342 (2008).
  CAS PubMed Google Scholar
• Cheok, C. F., Verma, C. S., Baselga, J. & Lane, D. P. Translating p53 into the clinic. Nature Rev. Clin. Oncol. 8, 25–37 (2011).
  CAS Google Scholar
• Di Cintio, A., Di Gennaro, E. & Budillon, A. Restoring p53 function in cancer: novel therapeutic approaches for applying the brakes to tumorigenesis. Recent Pat. Anticancer Drug Discov. 5, 1–13 (2010).
  CAS PubMed Google Scholar
• Mandinova, A. & Lee, S. W. The p53 pathway as a target in cancer therapeutics: obstacles and promise. Sci. Transl. Med. 3, 64rv1 (2011).
  CAS PubMed PubMed Central Google Scholar
• Brown, C. J., Cheok, C. F., Verma, C. S. & Lane, D. P. Reactivation of p53: from peptides to small molecules. Trends Pharmacol. Sci. 32, 53–62 (2011).
  CAS PubMed Google Scholar
• Petroski, M. D. The ubiquitin system, disease, and drug discovery. BMC Biochem. 9 (Suppl. 1), S7 (2008).
  PubMed PubMed Central Google Scholar
• Vu, B. T. & Vassilev, L. Small-molecule inhibitors of the p53-MDM2 interaction. Curr. Top. Microbiol. Immunol. 348, 151–172 (2011).
  CAS PubMed Google Scholar
• Colland, F. et al. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol. Cancer Ther. 8, 2286–2295 (2009).
  CAS PubMed Google Scholar
• Nicholson, B., Marblestone, J. G., Butt, T. R. & Mattern, M. R. Deubiquitinating enzymes as novel anticancer targets. Future Oncol. 3, 191–199 (2007).
  CAS PubMed Google Scholar
• Adams, J. & Kauffman, M. Development of the proteasome inhibitor Velcade (bortezomib). Cancer Invest. 22, 304–311 (2004).
  CAS PubMed Google Scholar
• McConkey, D. J. & Zhu, K. Mechanisms of proteasome inhibitor action and resistance in cancer. Drug Resist. Updat. 11, 164–179 (2008).
  CAS PubMed Google Scholar
• Eldridge, A. G. & O'Brien, T. Therapeutic strategies within the ubiquitin proteasome system. Cell Death Differ. 17, 4–13 (2010).
  CAS PubMed Google Scholar
• Grimm, S., Höhn, A. & Grune, T. Oxidative protein damage and the proteasome. Amino Acids 17 Jun 2010 (doi:10.1007/s00726-010-064620118).
• Rodriguez-Gonzalez, A. et al. Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer. Oncogene 27, 7201–7211 (2008).
  CAS PubMed PubMed Central Google Scholar
• Lee, J. T. & Gu, W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 17, 86–92 (2010).
  CAS PubMed Google Scholar
• Cummins, J. M. et al. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 1 Apr 2004 (doi:10.1038/nature02501). Definitive evidence that the DUB HAUSP stabilizes p53 indirectly through MDM2 deubiquitylation.
  PubMed Google Scholar
• Kon, N. et al. Inactivation of HAUSP in vivo modulates p53 function. Oncogene 29, 1270–1279 (2010).
  CAS PubMed Google Scholar
• Kon, N. et al. Roles of HAUSP-mediated p53 regulation in central nervous system development. Cell Death Differ. 25 Feb 2011 (doi:10.1038/cdd.2011.12).
  CAS Google Scholar
• Meulmeester, E., Pereg, Y., Shiloh, Y. & Jochemsen, A. G. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle 4, 1166–1170 (2005).
  CAS PubMed Google Scholar